Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

VREX stock hub

Varex Imaging Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

VREXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

414.3M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

VREX

In the news

Latest news · VREX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-15.7

P25 -105.6P50 -46.5P75 -3.1

ROIC8.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All VREX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

218

Groups with data

Currency

USD

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001681622
Company name	Varex Imaging Corporation
Country	United States
Country code	US
Cusip	92214X106
Employees	2,400
Employees Change	100%
Employees Change Percent	4.35
Enterprise value	$707M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Isin	US92214X1063
Last refreshed	2026-05-10
Market cap	$414.3M
Market cap category	Small-Cap
Price	$9.83
Price currency	USD
Rev Per Employee	357,291.67x
Sector	Healthcare
Sic	3679
Symbol	VREX
Website	https://www.vareximaging.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-19.96%
EV Sales Forward	0.79x
EV/EBIT	11.29x
EV/EBITDA	7.88x
EV/Sales	0.82x
FCF yield	-7.43%
Forward P/E	10.98x
P/B ratio	0.87x
P/S ratio	0.48x
PE Ratio10 Y	50.39x
PEG ratio	0.73x
PS Forward	0.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.3%
EBITDA Margin	10.46%
Gross margin	33.55%
Gross Profit	$287.7M
Gross Profit Growth	3.04%
Gross Profit Growth Q	-5.35%
Gross Profit Growth3 Y	0.44%
Gross Profit Growth5 Y	7.92%
Net Income	$-82.7M
Net Income Growth Years	0%
Pretax Margin	-8.76%
Profit Margin	-9.64%
Profit Per Employee	$-34,458
ROA	3.2
Roa5y	3.62
ROCE	7
ROE	-15.68
Roe5y	-0.81
ROIC	8.09
Roic5y	-1.34

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	20.33%
Cagr3y	-23.56%
Cagr5y	-16.71%
EPS Growth Years	0
Revenue Growth	3.63x
Revenue Growth Q	1.46x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	-0.85x
Revenue Growth5 Y	3.51x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.7
Assets	$1.1B
Cash	$88.3M
Current Assets	$625.6M
Current Liabilities	$195.3M
Debt	$381M
Debt EBITDA	$3.97
Debt Equity	$0.78
Equity	$488.1M
Interest Coverage	1.48
Liabilities	$601.3M
Long Term Assets	$463.8M
Long Term Liabilities	$406M
Net Cash	$-292.7M
Net Cash By Market Cap	$-70.65
Net Debt EBITDA	$3.26
Net Debt Equity	$0.6
Tangible Book Value	$263.2M
Tangible Book Value Per Share	$6.24
WACC	9.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.2
Inventory Turnover	1.8
Net Working Capital	$365.7M
Quick ratio	1.21
Working Capital	$430.3M
Working Capital Turnover	$1.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.58%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	20.32%
200-day SMA	11.72
3Y total return	-55.34%
50-day SMA	11.46
50-day SMA vs 200-day SMA	50under200
5Y total return	-59.91%
All Time High	43.76
All Time High Change	-77.54%
All Time High Date	2018-01-29
All Time Low	6.76
All Time Low Change	45.41%
All Time Low Date	2025-05-09
ATR	0.68
Beta	0.96
Beta1y	2.75
Beta2y	2.23
Ch YTD	-15.62
High	11.39
High52	14.57
High52 Date	2026-01-22
High52ch	-32.51%
Low	9.09
Low52	6.76
Low52 Date	2025-08-01
Low52ch	45.41%
Ma50ch	-14.19%
Price vs 200-day SMA	-16.14%
RSI	33.3
RSI Monthly	41.66
RSI Weekly	38.22
Sharpe ratio	0.54x
Sortino ratio	0.85
Total Return	-1.58%
Tr YTD	-15.62
Tr1m	-7.18%
Tr1w	-15.33%
Tr3m	-29.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$0.21
Earnings EPS Estimate Growth	-32.26
Earnings Revenue Estimate	216,976,000x
Earnings Revenue Estimate Growth	1.91x
Operating Income	$62.6M
Operating Income Growth	17.01
Operating Income Growth Q	-34.84
Operating Income Growth3 Y	-5.55
Operating margin	7.3
Price target	$16.67
Price Target Change	$69.58

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	41,446,426%
Float Percent	98.34%
Net Borrowing	-224,000,000
Shares Insiders	1.66%
Shares Institutions	97.1%
Shares Out	42,146,485
Shares Qo Q	-0.71%
Shares Yo Y	1.58%
Short Float	3.32%
Short Ratio	5.61
Short Shares	3.26

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-45.7M
Average Volume	367,896.05x
Bv Per Share	11.25
CAPEX	$-28.8M
Ch1m	-7.18
Ch1w	-15.33
Ch1y	20.32
Ch3m	-29.79
Ch3y	-55.34
Ch5y	-59.91
Ch6m	-17.88
Change	-16.91%
Change From Open	-13.47
Close	11.83
Days Gap	-3.97
Depreciation Amortization	27,100,000
Dollar Volume	16,912,937.7
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$62.6M
EBITDA	$89.7M
EPS	$-1.99
F Score	4
FCF	$-30.8M
FCF EV Yield	-4.36x
FCF Per Share	$-0.73
Financing CF	-231,000,000
Fiscal Year End	October
Founded	2,016
Goodwill	197,800,000
Income Tax	$7.4M
Investing CF	-12,200,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-04-03
Last Split Type	Never
Last10k Filing Date	2025-11-18
Ma150	12.1
Ma150ch	-18.77%
Ma20	11.78
Ma20ch	-16.52%
Net CF	-244,500,000
Next Earnings Date	2026-08-06
Open	11.36
Optionable	Yes
Position In Range	32.17
Post Close	9.83
Postmarket Change Percent	0.2
Postmarket Price	$9.85
Ppne	192,400,000
Price Date	2026-05-08
Price EBITDA	$4.62
Ptbv Ratio	1.57
Relative Volume	4.68x
Revenue	857,500,000x
SBC By Revenue	1.74x
Share Based Comp	14,900,000
Tax By Revenue	0.86x
Tr6m	-17.88%
Us State	Utah
Volume	1,720,543
Z Score	1.88

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does VREX pay a dividend?

Capital-return profile for this ticker.

Performance

VREX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns VREX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+97.1%

Float: +98.3% of shares outstanding

Insider ownership

+1.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

VREX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

33.3

Neutral momentum band

Price vs 200-day MA

-16.1%

50/200-day relationship not available

Beta (5Y)

0.96

Moves roughly with the market

Sharpe ratio

0.54

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About VREX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current VREX stock rating?

Varex Imaging Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full VREX analysis?

The full report lives at /stocks/VREX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for VREX?

The latest report frames VREX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the VREX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.